Pharmaceutical giant GSK has upgraded its 2025 guidance after solid growth across all divisions helped lift sales, profit and earnings. For the three months to the 30th September, the firm reported sales of £8.5 billion, up 7% at actual exchange rates (AER) and 8% at constant exchange rates (CER).  The performance was led by Specialty … Continue reading GSK upgrades 2025 guidance as profit climbs to £2.6bn